PAVmed (PAVM) Long-Term Investments (2024 - 2026)
PAVmed (PAVM) posted quarterly Long-Term Investments of $34.1 million for Q4 2025, up 33.09% year-over-year from $25.6 million in Q4 2024, and up 7.92% quarter-over-quarter from $31.6 million in Q3 2025.
PAVmed (PAVM) Long-Term Investments (2024 - 2026) Analysis & Trends
PAVmed's Long-Term Investments history runs 2 years deep, the most recent figure standing at $34.1 million for Q4 2025.
- In Q4 2025, Long-Term Investments rose 33.09% year-over-year to $34.1 million; the TTM figure through Dec 2025 stood at $34.1 million (up 33.09% YoY), while the FY2025 annual figure was $34.1 million, up 33.09% from the prior year.
- Long-Term Investments for Q4 2025 stood at $34.1 million, up from $31.6 million in the prior quarter.
- The five-year high for Long-Term Investments was $46.6 million in Q1 2025, with the low at $25.6 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 1.11 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 2.25 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 244.10 Mn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 175.52 Mn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | - |
| 10 | PAVmed | 32.48 Mn | 28.69 Mn | -89,000.00 | 33.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.49 Mn |
| Dec 31, 2025 | 34.12 Mn |
| Sep 30, 2025 | 31.62 Mn |
| Jun 30, 2025 | 36.00 Mn |
| Mar 31, 2025 | 46.64 Mn |
| Dec 31, 2024 | 25.64 Mn |